Literature DB >> 29661924

C9orf72 expansion is associated with accelerated decline of respiratory function and decreased survival in amyotrophic lateral sclerosis.

Gabriel Miltenberger-Miltenyi1, Vasco A Conceição1, Marta Gromicho1, Ana Catarina Pronto-Laborinho1, Susana Pinto1, Peter M Andersen2, Mamede de Carvalho1,3.   

Abstract

Entities:  

Keywords:  ALS; C9orf; respiratory medicine

Year:  2018        PMID： 29661924     DOI： 10.1136/jnnp-2018-318032

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  4 in total

1.  Survival and Prognostic Factors in C9orf72 Repeat Expansion Carriers: A Systematic Review and Meta-analysis.

Authors:  Stella A Glasmacher; Charis Wong; Iona E Pearson; Suvankar Pal
Journal:  JAMA Neurol       Date:  2020-03-01       Impact factor: 18.302

Review 2.  Therapeutic utility of mesenchymal stromal cell (MSC)-based approaches in chronic neurodegeneration: a glimpse into underlying mechanisms, current status, and prospects.

Authors:  Mohaddeseh Rahbaran; Angelina Olegovna Zekiy; Mahta Bahramali; Mohammadsaleh Jahangir; Mahsa Mardasi; Delaram Sakhaei; Lakshmi Thangavelu; Navid Shomali; Majid Zamani; Ali Mohammadi; Negin Rahnama
Journal:  Cell Mol Biol Lett       Date:  2022-07-16       Impact factor: 8.702

3.  Genetic factors for survival in amyotrophic lateral sclerosis: an integrated approach combining a systematic review, pairwise and network meta-analysis.

Authors:  Wei-Ming Su; Xiao-Jing Gu; Qing-Qing Duan; Zheng Jiang; Xia Gao; Hui-Fang Shang; Yong-Ping Chen
Journal:  BMC Med       Date:  2022-06-27       Impact factor: 11.150

4.  The C9orf72 expansion is associated with accelerated respiratory function decline in a large Amyotrophic Lateral Sclerosis cohort.

Authors:  James Rooney; Deirdre Murray; Anna Campion; Hannah Moloney; Rachel Tattersall; Mark Doherty; Michaela Hammond; Mark Heverin; Russell McLaughlin; Orla Hardiman
Journal:  HRB Open Res       Date:  2019-09-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.